Corrigendum

MPDU1 mutations underlie a novel human congenital disorder of glycosylation, designated type If

Barbara Schenk¹, Timo Imbach^1,2, Christian G. Frank¹, Claudia E. Grubenmann², Gerald V. Raymond³, Haggit Hurvitz⁴, Annick Raas-Rotschild⁵, Anthony S. Luder⁶, Jaak Jaeken⁷, Eric G. Berger², Gert Matthijs⁸, Thierry Hennet², Markus Aebi¹ and Jaak Jaeken⁷

¹Institute of Microbiology, Swiss Federal Institute of Technology, Zurich, Switzerland
² Institute of Physiology, University of Zurich, Switzerland
³ Kennedy Krieger Institute, Baltimore, Maryland, USA
⁴ Department of Pediatrics, Bikur Cholim Hospital, Jerusalem, Israel
⁵ Genetic Clinic, Hadassah University Hospital, Jerusalem, Israel
⁶ Department of Pediatrics, Sieff Hospital, Safed, Israel, and Faculty of Medicine, Technion, Haifa, Israel
⁷ Department of Pediatrics, University Hospital, Leuven, Belgium
⁸ Center for Human Genetics, Catholic University, Leuven, Belgium

Original citation: J. Clin. Invest.108:1687–1695 (2003). doi:10.1172/JCI13419.

Citation for this corrigendum: J. Clin. Invest.111:925 (2003). doi:10.1172/JCI13419C1.

Barbara Schenk,¹ Timo Imbach,² Christian G. Frank,¹ Claudia E. Grubenmann,² Gerald V. Raymond,³ Haggit Hurvitz,⁴ Isabelle Korn-Lubetzki,⁴ Shoshana Revel-Vik,⁴ Annick Raas-Rotschild,⁵ Anthony S.Luder,⁶ Jaak Jaeken,⁷ Eric G. Berger,² Gert Matthijs,⁸ Thierry Hennet,² and Markus Aebi¹

¹Institute of Microbiology, Swiss Federal Institute of Technology, Zurich, Switzerland ²Institute of Physiology, University of Zurich, Switzerland ³Kennedy Krieger Institute, Baltimore, Maryland, USA ⁴Department of Pediatrics, Bikur Cholim Hospital, Jerusalem, Israel ⁵Genetic Clinic, Hadassah University Hospital, Jerusalem, Israel ⁶Department of Pediatrics, Sieff Hospital, Safed, Israel, and Faculty of Medicine, Technion, Haifa, Israel ⁷Department of Pediatrics, University Hospital, Leuven, Belgium ⁸Center for Human Genetics, Catholic University, Leuven, Belgium